Strides Arcolab has hit a new 52-week high today at Rs.497.90 with volumes jumping up almost 2.5 times. It has come off its high but remains strongly in green, up 5% at Rs.489.

The stock has hit a high after the company announced that its Oral Dosage Forms manufacturing site (KRS Gardens) in Bangalore was recently inspected by the United States Food and Drug Administration (US FDA) as part of GMP compliance audit and the facility continues to be approved. The last US FDA inspection and approval for this facility was in the year 2011.

The KRS Gardens facility in Bangalore manufactures oral dosage forms such as tablets and capsules (both hard gelatine and soft gelatine). The manufacturing plant supports important current and future submissions for the US Market.